Back to News
Market Impact: 0.3
Bio-Rad Laboratories (BIO) Q3 Earnings Top Estimates
Source: zacks.com
Corporate EarningsHealthcare & Biotech
Bio-Rad Laboratories reported quarterly earnings of $2.65 per share, $0.04 above the Zacks Consensus Estimate of $2.61. Earnings increased from $2.26 per share a year earlier.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
BIO0.45
More News
- Bio-Rad earnings up next: Can diagnostics firm sustain momentum?
- Qualcomm issues disappointing earnings forecast as memory shortage weighs on smartphone sales
- ‘Seismic’ blue wave triggers the sinking of oil prices, energy stocks, and the chances of power permitting reform
- Nifty Bounces Back to Beat All of Asia on Foreign Flows, Earnings
- Snap shares fall over 10% on third-quarter earnings miss
- What Democrats’ midterm sweep means for your investments